CSIMarket Company Name, Ticker, Customers, else..
 
Bluelinx Holdings Inc   (NYSE: BXC)
Other Ticker:  
 
 

Bluelinx Holdings Inc Income Statement Quarterly

BXC


Download as CSV


Select the Financial Report:   Period:

New: More BXC's historic Income Statements >>

INCOME STATEMENT
(Quarterly GAAP In millions $)

 (Sep 27 2025)
Q3 2025		 (Jun 28 2025)
Q2 2025		 (Mar 29 2025)
Q1 2025		 (Dec 28 2024)
Q4 2024		 (Sep 28 2024)
Q3 2024
Revenue From Contract With Customer Excluding Assessed Tax 748.87 780.11 709.23 747.29
Other Revenue - - - -0.62
Total Revenue 748.87 780.11 709.23 712.74 746.67
Cost of Goods and Services Sold 640.68 660.42 598.10 599.39 621.00
Gross Profit 108.19 119.69 111.13 113.35 125.67
Selling, Administration, Marketing 89.28 95.27 94.09 92.62 92.21
Gain (Loss) on Disposition of Property Plant Equipment - - - -0.27 -
Depriciation & Amortization 9.74 9.79 9.55 9.41 9.53
Research & development - - - - -
Defined Benefit Plan, Recognized Net (Gain) Loss Due to Settlements - - - -0.26 -2.23
Other operatinig exp. /-income 0.18 0.58 -2.26 -3.13 3.11
Unusual Expense /-Income - - - - -
Amortization Of Deferred Gains From Real Estate - - - 2.95 -0.98
Amortization Of Deferred Gains On Real Estate -0.98 -0.98 -0.98 - -
Total operating costs including COS 738.90 765.07 698.50 700.71 722.64
Operating income/-loss 9.97 15.04 10.72 12.03 24.03
Other Deductions / - Income
Interest expense 8.60 8.46 6.58 5.32 4.62
Interest income - - - - -
Net interest expense/-income 8.60 8.46 6.58 5.32 4.62
Loss/ -Gain on Investment - - - - -
Foreign Currency Transaction (Gain) Loss - - - - -
Allowances, Health Care Trust Fund And Other - - - - -
Unexpected (Gain) Loss - - - - -
Other loss/ -income 0.00 0.00 0.00 -0.26 -2.23
Total costs & expenses 747.51 773.53 705.08 705.77 725.04
Income /-loss before income taxes 1.36 6.58 4.14 6.97 21.63
Income taxes expenses/-benefit -0.29 2.27 1.34 1.69 5.62
Income after income taxes 1.66 4.31 2.81 5.27 16.02
Net income/-loss of other equity - 0.00 - - 0.00
Income/-loss from cont. Ops. 1.66 4.31 2.81 5.27 16.02
Accounting change - - - - -
Discontinued operations - - - - -
Extraordinary items - - - - -
Net Income/-loss 1.66 4.31 2.81 5.27 16.02
Non-controlling interests - - - - -
Preferred dividends - - - - -
Other - - - - -
Income/-loss to shareholder 1.66 4.31 2.81 5.27 16.02
EBIT 9.97 15.04 10.72 12.29 26.25
EBITD 19.71 24.83 20.28 21.69 35.78
EBITDA 20.18 25.16 20.61 22.02 36.11


Per Share (GAAP Quarterly, in $) (Sep 27 2025)
Q3 2025		 (Jun 28 2025)
Q2 2025		 (Mar 29 2025)
Q1 2025		 (Dec 28 2024)
Q4 2024		 (Sep 28 2024)
Q3 2024
Basic EPS (excl. extra items) 0.20 0.54 0.33 0.64 1.88
   Extraordinary items 0.00 0.00 0.00 0.00 0.00
Basic Net EPS 0.20 0.54 0.33 0.64 1.88
Basic shares outstanding (Mill. of Units) 8.28 7.98 8.50 8.29 8.52
   EPS other shares - - - - -
Diluted Net EPS 0.20 0.54 0.33 0.64 1.87
Diluted average shares (Mill. of Units) 8.28 7.98 8.50 8.58 8.56
Dividend per share - - - - -


Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2025 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.